JP2015527303A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015527303A5 JP2015527303A5 JP2015518884A JP2015518884A JP2015527303A5 JP 2015527303 A5 JP2015527303 A5 JP 2015527303A5 JP 2015518884 A JP2015518884 A JP 2015518884A JP 2015518884 A JP2015518884 A JP 2015518884A JP 2015527303 A5 JP2015527303 A5 JP 2015527303A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- groups
- adjacent
- atoms
- coo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 11
- 239000004973 liquid crystal related substance Substances 0.000 claims 9
- 229910052731 fluorine Inorganic materials 0.000 claims 6
- -1 piperidine-1,4-diyl Chemical group 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims 4
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000006850 spacer group Chemical group 0.000 claims 2
- 125000005407 trans-1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])[C@]([H])([*:2])C([H])([H])C([H])([H])[C@@]1([H])[*:1] 0.000 claims 2
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12005046.3 | 2012-07-06 | ||
| EP12005046 | 2012-07-06 | ||
| PCT/EP2013/001772 WO2014005671A1 (en) | 2012-07-06 | 2013-06-14 | Bimesogenic compounds and mesogenic media |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015527303A JP2015527303A (ja) | 2015-09-17 |
| JP2015527303A5 true JP2015527303A5 (enExample) | 2016-08-04 |
| JP6523952B2 JP6523952B2 (ja) | 2019-06-05 |
Family
ID=48669856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015518884A Expired - Fee Related JP6523952B2 (ja) | 2012-07-06 | 2013-06-14 | ビメソゲン化合物およびメソゲン媒体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150203756A1 (enExample) |
| EP (1) | EP2870219B1 (enExample) |
| JP (1) | JP6523952B2 (enExample) |
| KR (1) | KR20150036407A (enExample) |
| CN (1) | CN104487542B (enExample) |
| TW (1) | TWI586791B (enExample) |
| WO (1) | WO2014005671A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014005672A1 (en) * | 2012-07-06 | 2014-01-09 | Merck Patent Gmbh | Bimesogenic compounds and mesogenic media |
| WO2014005670A1 (en) | 2012-07-06 | 2014-01-09 | Merck Patent Gmbh | Bimesogenic compounds and mesogenic media |
| CN104583366B (zh) * | 2012-08-29 | 2017-06-23 | 默克专利股份有限公司 | 双介晶化合物和介晶介质 |
| CN105555917B (zh) * | 2013-09-12 | 2019-03-01 | 默克专利股份有限公司 | 介晶化合物和介晶介质 |
| US20160289561A1 (en) * | 2013-11-22 | 2016-10-06 | Merck Patent Gmbh | Bimesogenic compounds and mesogenic media |
| JP6657088B2 (ja) * | 2013-11-22 | 2020-03-04 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | メソゲン媒体および液晶ディスプレイ |
| JP2017528429A (ja) * | 2014-07-17 | 2017-09-28 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ビメソゲン化合物およびメソゲン媒体 |
| CN104087311B (zh) * | 2014-07-21 | 2015-12-30 | 西安近代化学研究所 | 一种双介晶基元液晶化合物 |
| CN106281360B (zh) * | 2015-06-04 | 2019-02-15 | 江苏和成显示科技有限公司 | 液晶组合物及其应用 |
| CN106281359B (zh) * | 2015-06-04 | 2019-02-15 | 江苏和成显示科技有限公司 | 液晶组合物及其显示器件 |
| CN106281355B (zh) * | 2015-06-04 | 2019-02-15 | 江苏和成显示科技有限公司 | 液晶介质及其应用 |
| KR20180088705A (ko) * | 2015-12-02 | 2018-08-06 | 메르크 파텐트 게엠베하 | 액정 매질 및 액정 장치 |
| CN105549290B (zh) * | 2016-02-01 | 2019-07-23 | 京东方科技集团股份有限公司 | 显示面板和显示装置 |
| JP2019533037A (ja) * | 2016-09-14 | 2019-11-14 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | 液晶媒体および液晶デバイス |
| WO2019121368A1 (en) * | 2017-12-18 | 2019-06-27 | Merck Patent Gmbh | Liquid crystal medium and liquid crystal device |
| GB2583668A (en) * | 2017-12-18 | 2020-11-04 | Merck Patent Gmbh | Liquid crystal medium and liquid crystal device |
| WO2019179962A1 (en) * | 2018-03-22 | 2019-09-26 | Merck Patent Gmbh | Liquid-crystalline medium |
| CN110467926B (zh) * | 2018-05-10 | 2023-10-31 | 江苏集萃智能液晶科技有限公司 | 液晶组合物及其液晶显示器 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2516382A1 (de) * | 1974-04-18 | 1975-11-06 | Ciba Geigy Ag | Phenyl-aralkyl-aether, -thioaether und -amine |
| JPS54119476A (en) * | 1978-03-10 | 1979-09-17 | Ishihara Sangyo Kaisha Ltd | 4-(5-fluoromethyl-2-pyridyloxy)phenoxyalkanecarbocyic acid derivatives and their preparation |
| DE3040632A1 (de) * | 1980-10-29 | 1982-05-27 | Merck Patent Gmbh, 6100 Darmstadt | Cyclohexylphenylderivate, diese enthaltende dielektrika und elektrooptisches anzeigeelement |
| JPS63137985A (ja) * | 1986-11-28 | 1988-06-09 | Canon Inc | 強誘電性液晶素子 |
| JPS6436683A (en) * | 1987-07-31 | 1989-02-07 | Canon Kk | Ferroelectric liquid crystal element |
| DE4000451B4 (de) | 1990-01-09 | 2004-12-09 | Merck Patent Gmbh | Elektrooptisches Flüssigkristallschaltelement |
| EP1061404A1 (en) | 1992-09-18 | 2000-12-20 | Hitachi, Ltd. | A liquid crystal display device |
| GB2329636B (en) | 1996-07-01 | 2000-07-19 | Merck Patent Gmbh | Chiral dopants |
| DE19834162A1 (de) | 1997-08-13 | 1999-02-18 | Merck Patent Gmbh | Chirale Verbindungen |
| EP0971016B1 (en) | 1998-07-08 | 2003-05-21 | MERCK PATENT GmbH | Mesogenic estradiols |
| JP4336925B2 (ja) * | 1999-08-16 | 2009-09-30 | 信越化学工業株式会社 | レジスト材料及びパターン形成方法 |
| GB2356629B (en) * | 1999-10-04 | 2004-09-22 | Merck Patent Gmbh | Bimesogenic Compounds and Flexoelectric Devices |
| JP3750725B2 (ja) * | 1999-10-06 | 2006-03-01 | 信越化学工業株式会社 | レジスト材料及びパターン形成方法 |
| GB0225662D0 (en) * | 2001-11-16 | 2002-12-11 | Merck Patent Gmbh | Liquid crystalline medium and liquid crystal display |
| JP2003306433A (ja) * | 2002-02-18 | 2003-10-28 | Ishihara Sangyo Kaisha Ltd | ピリジン誘導体またはその塩ならびにそれらを含有するサイトカイン産生抑制剤 |
| US6875780B2 (en) * | 2002-04-05 | 2005-04-05 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods for their preparation |
| US7244763B2 (en) * | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| EP1477547B1 (en) * | 2003-05-09 | 2006-06-14 | MERCK PATENT GmbH | Liquid crystalline medium and liquid crystal display |
| SG145752A1 (en) * | 2003-09-19 | 2008-09-29 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| TW200538433A (en) * | 2004-02-24 | 2005-12-01 | Irm Llc | Immunosuppressant compounds and compositiions |
| DE602005006845D1 (de) * | 2004-12-23 | 2008-06-26 | Merck Patent Gmbh | Bimesogene verbindungen und flexoelektrische vorrichtungen |
| US8377519B2 (en) * | 2006-06-09 | 2013-02-19 | Merck Patent Gmbh | Liquid crystalline medium and liquid crystal display |
| US8669283B2 (en) * | 2008-02-26 | 2014-03-11 | Ludwig-Maximilians-Universitat Munchen | Beta-lactones as antibacterial agents |
| JP5423352B2 (ja) * | 2009-11-26 | 2014-02-19 | Ｊｓｒ株式会社 | 感放射線性樹脂組成物、液晶表示素子の層間絶縁膜、保護膜及びスペーサーならびにそれらの形成方法 |
| EP2729549B1 (en) * | 2011-07-05 | 2016-12-07 | Merck Patent GmbH | Bimesogenic compounds |
| JP5797132B2 (ja) * | 2012-03-07 | 2015-10-21 | 富士フイルム株式会社 | 化合物、液晶組成物、高分子材料およびフィルム |
| EP2855631B1 (en) * | 2012-05-25 | 2017-09-20 | Merck Patent GmbH | Mesogenic media and liquid crystal display |
| WO2014005672A1 (en) * | 2012-07-06 | 2014-01-09 | Merck Patent Gmbh | Bimesogenic compounds and mesogenic media |
| WO2014005670A1 (en) * | 2012-07-06 | 2014-01-09 | Merck Patent Gmbh | Bimesogenic compounds and mesogenic media |
| CN104583366B (zh) * | 2012-08-29 | 2017-06-23 | 默克专利股份有限公司 | 双介晶化合物和介晶介质 |
| WO2014090372A1 (en) * | 2012-12-10 | 2014-06-19 | Merck Patent Gmbh | Bimesogenic compounds and mesogenic media |
-
2013
- 2013-06-14 KR KR20157003134A patent/KR20150036407A/ko not_active Abandoned
- 2013-06-14 EP EP13730120.6A patent/EP2870219B1/en not_active Not-in-force
- 2013-06-14 WO PCT/EP2013/001772 patent/WO2014005671A1/en not_active Ceased
- 2013-06-14 US US14/413,064 patent/US20150203756A1/en not_active Abandoned
- 2013-06-14 CN CN201380035212.7A patent/CN104487542B/zh active Active
- 2013-06-14 JP JP2015518884A patent/JP6523952B2/ja not_active Expired - Fee Related
- 2013-07-05 TW TW102124298A patent/TWI586791B/zh not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015527303A5 (enExample) | ||
| JP2015527304A5 (enExample) | ||
| JP2015523334A5 (enExample) | ||
| JP2015527980A5 (enExample) | ||
| JP2015532649A5 (enExample) | ||
| JP2011174070A5 (enExample) | ||
| JP2003206485A5 (enExample) | ||
| JP2010163623A5 (enExample) | ||
| JP2013544233A5 (enExample) | ||
| JP2005120091A5 (enExample) | ||
| JP2016041804A5 (enExample) | ||
| JPH11349945A5 (enExample) | ||
| CN114555574A (zh) | 靶向醛酮还原酶1c3的苯并二氢吡喃类化合物 | |
| JP2010059430A5 (enExample) | ||
| JP2017088591A5 (enExample) | ||
| WO2013121449A8 (en) | Compositions and methods for the modulation of specific amidases for n-acylethanolamines for use in the therapy of inflammatory diseases | |
| JP2015180727A5 (enExample) | ||
| JP2009504814A5 (enExample) | ||
| JPH09124529A5 (enExample) | ||
| JP2016113583A5 (enExample) | ||
| CA2662517A1 (en) | Treatment of cancer | |
| JP2016164267A5 (enExample) | ||
| JP2016027008A5 (enExample) | ||
| JP2023061912A5 (enExample) | ||
| JP2014210935A5 (enExample) |